Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome

Blood

Volumn 87, Issue 9, 1996, Pages 3625-3632

  Mauch, Peter M ^a   Kalish, Leslie A ^b   Marcus, Karen C ^b   Coleman, C Norman ^b   Shulman, Lawrence N ^b   Krill, Elisa ^b   Come, Steven ^b   Silver, Barbara ^b   Canellos, George P ^b   Tarbell, Nancy J ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SECOND CANCER; SOLID TUMOR; TREATMENT OUTCOME;

EID: 1842287357     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3625.bloodjournal8793625     Document Type: Article

References (55)

1. Arseneau J, Sponzo R, Levin D, Schnipper L, Bonner H, Young R, Canellos G, Johnson E, DeVita V: Nonlymphomatous malignant tumors complicating Hodgkin's disease. N Engl J Med 287:1119, 1972
2. Canellos G, DeVita V, Arseneau J, Whang-Peng J, Johnson R: Second malignancies complicating Hodgkin's disease in remission. Lancet 1:947, 1975
3. Coleman C, Williams C, Flint A, Glatstein E, Rosenberg S, Kaplan H: Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 297:1249, 1977
4. Krikorian J, Burke J, Rosenberg S, Kaplan H: Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 300:452, 1979
5. Bergsagel D, Alison R, Bean H, Brown T, Bush R, Clark R, Chua T, Dalley D, DeBoer G, Gospodarowicz M, Hasselback R, Perrault D, Rideout D: Results of treating Hodgkin's disease without a policy of laparotomy staging. Cancer Treat Rep 66:717, 1982
6. Coleman C, Kaplan H, Cox R, Varghese A, Butterfield P, Rosenburg S: Leukaemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease. Cancer Surv 1:733, 1982
7. Coltman C, Dixon D: Second malignancies complicating Hodgkin's disease: A Southwest Oncology Group 10-year followup. Cancer Treat Rep 66:1023, 1982
8. Glicksman A, Pajak T, Gottlieb A, Nissen N, Stutzman L, Cooper M: Second malignant neoplasms in patients successfully treated for Hodgkin's disease Cancer Treat Rep 66:1023, 1982
9. Henry-Amar M: Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. J Natl Cancer Inst 71:911, 1983
10. Boivin J, Hutchison G, Lyden M, Godbold J, Chorosh J, Schottenfeld D: Second primary cancers following treatment of Hodgkin's disease. J Natl Cancer Inst 72:233, 1984
11. Tester W, Kinsella T, Waller B, Makuch R, Kelley P, Glatstein E, DeVita V: Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience. J Clin Oncol 2:762, 1984
12. Tucker M, Misfeldt D, Coleman C, Clark W, Rosenberg S: Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 102:37, 1985
13. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonnadonna G: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830, 1986
14. Blayney D, Longo D, Young R, Greene M, Hubbard S, Postal M, Duffey P, DeVita V: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316:710, 1987
15. Pedersen-Bjergaard J, Specht L, Larsen S: Risk of therapy related leukemia and pre-leukemia after Hodgkin's disease. Lancet 2:83, 1987
16. Van Leeuwen F, Somers R, Hart A: Splenectomy in Hodgkin's disease and second leukemias. Lancet 2:210, 1987
17. Boivin J, O'Brien K: Solid cancer risk after treatment of Hodgkin's disease. Cancer 61.2541, 1988
18. Curtis R, Boice J: Second cancers after radiotherapy for Hodgkin's disease. N Engl J Med 319:244, 1988
19. Prior P, Pope D: Subsequent primary cancers in relation to treatment. Br J Cancer 58:512, 1988
20. Tucker M, Coleman C, Cox R, Varghese A, Rosenberg S: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76, 1988
21. Henry-Amar M, Pellae-Cosset B, Bayle-Weisgerber C: Risk of secondary acute leukemia and preleukemia after Hodgkin's disease. Recent Results Cancer Res 117 270, 1989
22. Van Leeuwen F, Somers R, Taal B, van Heerde P, Coster B, Dozeman T, Huisman S, Hart A: Increased risk of lung cancer, non-Hodgkin's lymphoma and leukemia following Hodgkin's disease. J Clin Oncol 7:1046, 1989
23. Devereux S, Selassie T, Vaughan Hudson G, Vaughan Hudson B, DC L: Leukemia complicating treatment for Hodgkin's disease. Br Med J 301:1077, 1990
24. Kaldor J, Day N, Clarke A, van Leeuwen F, Henri-Amar M, Finentino M, Bell J, Pedersen D, Band P, Assouline D: Leukemia following Hodgkin's disease. N Engl J Med 322:7, 1990
25. Abrahamsen J, Andersen A, Hannisdal E, Nome O, Abrahamsen A, Kvaloy S, Host H: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255, 1993
26. Hancock S, Tucker M, Hoppe R: Breast cancer after treatment for Hodgkin's disease. J Natl Cancer Inst 85:25, 1993
27. Tarbell N, Gelber R, Weinstein H, Mauch P: Sex differences in risk of second malignant tumours after Hodgkin's disease. Lancet 341:1428, 1993
28. Tura S, Fiacchini M, Zinzani P, Brusamolino E, Gobbi P: Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 11:925, 1993
29. Van Leeuwen F, Klokman W, Hagenbeek A, Noyon R, van den Belt-Dusebout A, van Kerkhoff E, van Heerde P, Somers R: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312, 1994
30. Biti G, Cellai E, Magrini S, Papi M, Ponticelli P, Boddi V: Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institution. Int J Radiat Oncol Biol Phys 29:25, 1994
31. DeVita V, Serpick A, Carbone P: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881, 1970
32. McKendrick J, Mead G, Sweetenham J, Jones D, Williams C, Ryall R, Whitehouse J: ChIVPP chemotherapy in advanced Hodgkin's disease. Eur J Cancer Clin Oncol 25:557, 1989
33. Jacquillat C, Khayat D, Desprez-Curely J, Weil M, Brocheriou C, Auclerc G, Chamseddine N, Bernard J: Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Cancer 53:459, 1984
34. Mauch P, Leonard R, Skarin A, Rosenthal D, Come S, Chaffey J, Hellman S, Canellos G: Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol 3:1301, 1985
35. Mauch P, Tarbell N, Weinstein H, Silver B, Goffman T, Osteen R, Zajac A, Coleman C, Canellos G, Rosenthal D: Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 6:1576, 1988
36. National Research Council, Committee on the biological effects of ionizing radiations: The effects on populations of exposure to low levels ot ionizing radiation. Washington, DC, National Academy of Sciences, 1980
37. Beyer W: Basic Statistical Tables. Cleveland, OH, Chemical Rubber Co, 1971, p 68
38. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
39. Peto R, Peto J: Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc A 135:185, 1972
40. Cox D: Regression models and life tables (with discussion). J R Stat Soc B 34:187, 1972
41. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's disease. Ann Oncol 3:117, 1992
42. Swerdlow A, Douglas A, Hudson G, Hudson B, Bennett M, MacLennan K: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients, in The British National Lymphoma Investigation. Br J Med 304:1137, 1992
43. Van Leeuwen F, Chorus A, van den Belt-Dusebout A, Hagenbeek A, Noyon R, van Kerkhoff E, Pinedo H, Somers R: Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number and episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063, 1994
44. Andrieu J-M, Ifrah N, Payen C, Fermanian J, Coscas Y, Flandrin G: Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 8:1148, 1990
45. Gyger M, Perreault C, Boileau J, Aymard J-P, Bonny Y, Lacombe M, Lavalee R, d'Angelo G, Tawil E: Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemia. Blood 61:1279, 1983
46. Colman M, Easton D, Horwich A, Peckham M: Second malignancies and Hodgkin's disease - The Royal Marsden Hospital experience. Radiother Oncol 11:229, 1988
47. List A, Doll D, Greco F: Lung cancer in Hodgkin's disease: Association with previous radiotherapy. J Clin Oncol 3:215, 1985
48. Cosset J, Henry-Amar M, Meerwaldt J, Carde P, Noordijk E, Thomas J, Burgers J, Somers R, Hayat M, Tubiana M: The EORTC trials for limited stage Hodgkin's disease. Eur J Cancer 11:1847, 1992
49. Canellos G, Anderson J, Propert K, Nissen N, Cooper M, Henderson E, Green M, Gottlieb A, Peterson B: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478, 1992
50. Mauch P, Coleman C. Mantle irradiation alone for selected patients with pathologically staged IA-IIA Hodgkin's disease: Preliminary results of a prospective trial. Int J Rad Oncol Biol Phys 27:231, 1993
51. Tubiana M, Henry-Amar M, Carde P, Burgers J, Hayat M, Van der Schueren E, Noordijk E, Tanguy A, Meerwaldt J, Thomas J, De Pauw B, Monconduit M, Cosset J, Somers R: Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 73:47, 1989
52. Mauch P: Controversies in the management of patients with early stage Hodgkin's disease. Blood 83:318, 1994
53. Leopold K, Canellos G, Rosenthal D, Shulman L, Weinstein H, Mauch P: Stage IA-IIB Hodgkin's disease: Staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol 7:1059, 1989
54. Rostock R, Giangreco A, Wharam M, Lenhard R, Siegelman S, Order S. CT scan modification in the treatment of mediastinal Hodgkin's disease. Cancer 49:2267, 1982
55. Rostock R, Siegelman S, Lenhard R, Wharam M, Order S: Thoracic CT scanning for mediastinal Hodgkin's disease: Results and therapeutic implications. Int J Radiat Oncol Biol Phys 9:1451, 1983